T cell protein could unlock new treatment for the most-feared joint replacement complication

Bone and joint infections cause significant health problems for patients and lead to millions of dollars in added health costs per year, but clinicians lack reliable tools to predict which patients will develop severe or persistent disease. And when standard-of-care antibiotics fall short, there are no immunotherapies available to help patients mount a stronger defense against infections.

≈